Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wedel

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
British Heart Journal|April 1, 1984
Effect of metoprolol on chest pain in acute myocardial infarctionJ Herlitz, A Hjalmarson, S Holmberg, et al.
American Heart Journal|August 30, 2001
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trialH Wedel, D Demets, P Deedwania, et al.
The American Journal of Cardiology|June 25, 1984
Göteborg Metoprolol Trial: design, patient characteristics and conductJ Herlitz, S Holmberg, K Pennert, et al.
International Journal of Clinical Practice|May 27, 2010
The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes TrialP Lindgren, J Eriksson, M Buxton, et al.
American Journal of Epidemiology|February 1, 1992
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, SwedenB Larsson, C Bengtsson, P Björntorp, et al.
Journal of Hypertension|October 1, 1987
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trialL Wilhelmsen, G Berglund, D Elmfeldt, et al.
Journal of Human Hypertension|February 15, 2013
ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial dataD Prieto-Merino, J Dobson, A K Gupta, et al.
Lancet (London, England)|June 23, 1998
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupL Hansson, A Zanchetti, S G Carruthers, et al.
Atherosclerosis. Supplements|November 9, 2004
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994T R Pedersen, J Kjekshus, K Berg, et al.
Journal of Hypertension|June 14, 2001
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study GroupA Zanchetti, L Hansson, B Dahlöf, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
British Heart Journal|April 1, 1984
Effect of metoprolol on chest pain in acute myocardial infarctionJ Herlitz, A Hjalmarson, S Holmberg, et al.
American Heart Journal|August 30, 2001
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trialH Wedel, D Demets, P Deedwania, et al.
The American Journal of Cardiology|June 25, 1984
Göteborg Metoprolol Trial: design, patient characteristics and conductJ Herlitz, S Holmberg, K Pennert, et al.
International Journal of Clinical Practice|May 27, 2010
The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes TrialP Lindgren, J Eriksson, M Buxton, et al.
American Journal of Epidemiology|February 1, 1992
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, SwedenB Larsson, C Bengtsson, P Björntorp, et al.
Journal of Hypertension|October 1, 1987
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trialL Wilhelmsen, G Berglund, D Elmfeldt, et al.
Journal of Human Hypertension|February 15, 2013
ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial dataD Prieto-Merino, J Dobson, A K Gupta, et al.
Lancet (London, England)|June 23, 1998
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupL Hansson, A Zanchetti, S G Carruthers, et al.
Atherosclerosis. Supplements|November 9, 2004
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994T R Pedersen, J Kjekshus, K Berg, et al.
Journal of Hypertension|June 14, 2001
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study GroupA Zanchetti, L Hansson, B Dahlöf, et al.
Pageof 17